Evolution of expression of cardiac phenotypes over a 4-year period in the β-myosin heavy chain-Q403 transgenic rabbit model of human hypertrophic cardiomyopathy

被引:44
作者
Nagueh, SF [1 ]
Chen, S [1 ]
Patel, R [1 ]
Tsybouleva, N [1 ]
Lutucuta, S [1 ]
Kopelen, HA [1 ]
Zoghbi, WA [1 ]
Quiñones, MA [1 ]
Roberts, R [1 ]
Marian, AJ [1 ]
机构
[1] Baylor Coll Med, Cardiol Sect, Dept Med, Houston, TX 77030 USA
关键词
transgenic animal models; cardiomyopathy; hypertrophy; genetics; ATPase; echocardiography; tissue Doppler;
D O I
10.1016/j.yjmcc.2004.02.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypertrophic cardiomyopathy (HCM), the most common cause Of Sudden cardiac death in the young, is characterized by a diverse array of cardiac phenotypes evolving over several decades. We have developed transgenic rabbits that fully recapitulate the phenotype of human HCM and provide for the opportunity to delineate the sequence of evolution of cardiac phenotypes, and thus, the pathogenesis of HCM. We determined evolution of biochemical, molecular, histological, structural and functional phenotypes at 4 age-periods in 47 P-myosin heavy chain-glutamine (MyHC-Q)-403 transgenic rabbits. Ca+2 sensitivity of myofibrillar ATPase activity was reduced very early and in the absence of other discernible phenotypes. Myocyte disarray also occurred early, prior to, and independent of hypertrophy and fibrosis. The latter phenotypes evolved predominantly during puberty in conjunction with activation of stress-related signaling kinases. Myocardial contraction and relaxation velocities were decreased early despite normal global cardiac function and in the absence of histological phenotype. Global cardiac function declined with aging, while left atrial size was increased along with Doppler indices of left ventricular filling pressure. Thus, Ca+2 sensitivity of myofibrillar ATPase activity is a primary phenotype expressed early and independent of the ensuing phenotypes. Pathogenesis of myocyte disarray, which exhibits age-independent penetrance, differs from those of hypertrophy and fibrosis, which show age-dependent expression. Myocardial dysfunction is an early marker that predicts subsequent development of hypertrophy. These findings in an animal model that recapitulates the phenotype of human HCM, implicate involvement of multiple independent mechanisms in the pathogenesis of cardiac phenotypes in HCM. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:663 / 673
页数:11
相关论文
共 29 条
[1]   Molecular mechanics of mouse cardiac myosin isoforms [J].
Alpert, NR ;
Brosseau, C ;
Federico, A ;
Krenz, M ;
Robbins, J ;
Warshaw, DM .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2002, 283 (04) :H1446-H1454
[2]   Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death [J].
Bueno, OF ;
Molkentin, JD .
CIRCULATION RESEARCH, 2002, 91 (09) :776-781
[3]   Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy [J].
Crilley, JG ;
Boehm, EA ;
Blair, E ;
Rajagopalan, B ;
Blamire, AM ;
Styles, P ;
McKenna, WJ ;
Östman-Smith, I ;
Clarke, K ;
Watkins, H .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (10) :1776-1782
[4]   HYPERTROPHIC CARDIOMYOPATHY - PATHOLOGY AND PATHOGENESIS [J].
DAVIES, MJ ;
MCKENNA, WJ .
HISTOPATHOLOGY, 1995, 26 (06) :493-500
[5]   Molecular mechanisms of inherited cardiomyopathies [J].
Fatkin, D ;
Graham, RM .
PHYSIOLOGICAL REVIEWS, 2002, 82 (04) :945-980
[6]   A mouse model of familial hypertrophic cardiomyopathy [J].
GeisterferLowrance, AAT ;
Christe, M ;
Conner, DA ;
Ingwall, JS ;
Schoen, FJ ;
Seidman, CE ;
Seidman, JG .
SCIENCE, 1996, 272 (5262) :731-734
[7]   The molecular genetic basis for hypertrophic cardiomyopathy [J].
Marian, AJ ;
Roberts, R .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (04) :655-670
[8]   A transgenic rabbit model for human hypertrophic cardiomyopathy [J].
Marian, AJ ;
Wu, Y ;
Lim, DS ;
McCluggage, M ;
Youker, K ;
Yu, QT ;
Brugada, R ;
DeMayo, F ;
Quinones, M ;
Roberts, R .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (12) :1683-1692
[9]  
MARIAN AJ, 2000, HEART PHYSL PATHOPHY, P1045
[10]   Hypertrophic cardiomyopathy - A systematic review [J].
Maron, BJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (10) :1308-1320